Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...

Amgen's AMGN short percent of float has risen 11.27% since its last report. The company recently reported that it has 12.74 million shares sold short, which is 2.37% of all regular shares that are ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We came across a bullish thesis on Amgen Inc. (AMGN) on Substack by Disruptive analytics. In this article, we will summarize ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

This makes it worthwhile to examine what the stock has in store. The rise in CRISPR Therapeutics' share price can be attributed ... CRISPR Therapeutics (NASDAQ: CRSP), Amgen (NASDAQ: AMGN ...

And perhaps unsurprisingly, given its cutting edge research interests, the company recorded losses for five years straight, forcing Amgen to issue stock several ... in share price and profit ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.